TsuyukiRTJohnsonJATeoKKA randomized trial of the effect of community pharmacist intervention on cholesterol risk: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med2002;162:1149–55.
2.
TsuyukiRTOlsonKLDubykAMEffect of community pharmacist intervention on cholesterol levels in patients with high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus). Am J Med2004;116:130–3.
3.
TsuyukiRTSchindelTJ. Pharmacy practice change: the leadership challenge. Can Pharm J2008;141:174–80.
PearsonGJThompsonAESemchukW. Guidelines for the management of dyslipidemia and prevention of cardiovascular disease by pharmacists. Can Pharm J2008;141[Suppl 2]:S11–6.